Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Epithelial-to-mesenchymal transition (EMT) endows tumor cells with the ability to invade and migrate, and to suppress antitumor immunity. In this issue, Parajuli and colleagues report that EMT tumors often express the RNA-binding protein AT-rich interactive domain 5a (Arid5a), which they find stabilizes the mRNAs encoding indoleamine 2,3 dioxygenase (IDO1) and CCL2. As a new link between EMT and tumoral immune resistance, Arid5a represents a therapeutic target of interest.See related article by Parajuli et al., p. 862 (4).

More information Original publication

DOI

10.1158/2326-6066.CIR-21-0432

Type

Journal article

Publication Date

2021-08-01T00:00:00+00:00

Volume

9

Keywords

Animals, DNA-Binding Proteins, Mice, Mice, Inbred C57BL, RNA, Messenger, RNA-Binding Proteins, Transcription Factors